Multicenter Observational Program Evaluation of the Efficacy and Tolerability of Detralex Treatment in Patients With Chronic Venous Edema (CEAP Class С3) in Real Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2019
Price : $35 *
At a glance
- Drugs S 5682 (Primary)
- Indications Oedema
- Focus Therapeutic Use
- Sponsors Servier
- 14 Oct 2019 Planned End Date changed from 10 Jun 2019 to 10 Dec 2019.
- 10 Jan 2019 Status changed from not yet recruiting to recruiting.
- 02 Nov 2018 New trial record